References
- 1. Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016 Jan; 38(1):11-27. DOI: 10.1007/s00281-015-0539-8
- 2. Zhao YE, Hu L, Ma JX, Xiao SX, Zhao YL. Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis. J Eur Acad Dermatol Venereol. 2014 Mar; 28(3):355-69. DOI: 10.1111/jdv.12256
- 3. Safer JD, Fraser LM, Ray S, Holick MF. Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats. Thyroid. 2001 Aug; 11(8):717-24. DOI: 10.1089/10507250152484547
- 4. Roman II, Constantin AM, Marina ME, Orasan RI. The role of hormones in the pathogenesis of psoriasis vulgaris. Clujul Med. 2016 Jan; 89(1):11-8. DOI: 10.15386/cjmed-505
- 5. Kanda N, Hau C, Tada Y, Watanabe S. Prolactin May Promote the Development of Psoriasis: Reawakened Issue. J Clin Exp Dermatol Res. 2013 Dec; 4:198.
- 6. Al-Shobaili HA, Quresh MG. Pathophysiology of Psoriasis: Current Concepts. In Hermenio L, editor. Psoriasis - Types, Causes and Medication. Croatia: InTech; 2013. p. 91-105.
- 7. Lønnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Heritability of psoriasis in a large twin sample. Br J Dermatol. 2013 Aug; 169(2):412-6. DOI: 10.1111/bjd.12375
- 8. Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B, Olafsson JH, Petersen H, Sigurdsson MI, et al. HLACw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series. J Am Acad Dermatol. 2016 Nov; 75(5):889-96. DOI: 10.1016/j.jaad.2016.06.061
- 9. Campione E, Diluvio L, Terrinoni A, Orlandi A, Latino MP, Torti C, et al. Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports. BMC Res Notes. 2014 Dec; 7:929. DOI: 10.1186/1756-0500-7-929
- 10. Singh S, Singh VR, Pandey SS. Psoriasis in identical twins: simultaneous occurance on same sites. Indian J Dermatol Venereol Leprol. 1996 Sep-Oct; 62(5):308-9.
- 11. Gudjonsson JE, Karason A, Antonsdottir AA, Runarsdottir EH, Gulcher JR, Stefansson K, et al. HLA-Cw6-Positive and HLA-Cw6-Negative Patients with Psoriasis Vulgaris have Distinct Clinical Features. J Invest Dermatol. 2002 Feb; 118(2):362-5. DOI: 10.1046/j.0022-202x.2001.01656.x
- 12. Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford). 2016 Feb; 55(2):221-9. DOI: 10.1093/rheumatology/kev296
- 13. Ho PY, Barton A, Worthington J, Plant D, Griffiths CEM, Young HS, et al. Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis. Ann Rheum Dis. 2008 May; 67(5):677-682. DOI: 10.1136/ard.2007.071399
- 14. Ng J, Tan AL, McGonagle D. Unifocal psoriatic arthritis development in identical twins following site specific injury: evidence supporting biomechanical triggering events in genetically susceptible hosts. Ann Rheum Dis. 2015 May; 74(5):948-9. DOI: 10.1136/annrheumdis-2014-206784
- 15. Foitzik K, Langan EA, Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. Journal of Investigative Dermatology. 2009 May; 129(5):1071-87. DOI: 10.1038/ jid.2008.348
- 16. Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005 Apr; 38(1):1-7. DOI: 10.1016/j.jdermsci. 2004.10.011
- 17. Capozzi A, Scambia G, Pontecorvi A, Lello S. Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecol Endocrinol. 2015 Jul; 31(7):506-10. DOI: 10.3109/09513590.2015.1017810
- 18. Langan EA, Griffiths CEM, Paus R. Langan EA, Griffiths CEM, Paus R. Arch of Derm Res. 2012 Mar; 304(2):115-8. DOI: 10.1007/s00403-012-1208-6
- 19. Kato AM, Gheida SF, El-Bendary AS. Serum level of prolactin in psoriatic patients. EDOJ. 2012; 8(2):1-12.
- 20. Angioni AR, Lania A, Cattaneo A, Beck-Peccoz P, Spada A. Effects of chronic retinoid administration on pituitary function. J Endocrinol Invest. 2005 Dec; 28(11):961-4. DOI: 10.1007/BF03345332
- 21. Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem. 2011 Oct; 44(14-15):1209-13. DOI: 10.1016/j.clinbiochem.2011.07.009
- 22. Arican O, Bilgic K, Koc K. The effect of thyroid hormones in psoriasis vulgaris. Indian J Dermatol Venereol Leprol. 2004 Nov-Dec; 70(6):353-6.
- 23. Gnanaraj P, Dayalan H, Elango T, Malligarjunan H, Raghavan V, Rao R. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis. Int J Dermatol. 2015 Mar; 54(3):302-6. DOI: 10.1111/ijd.12565
- 24. Antonelli A, Delle Sedie A, Fallahi P, Ferrari SM, Maccheroni M, Ferrannini E, et al. High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis. J Rheumatol. 2006 Oct; 33(10):2026-8.
- 25. Gisondi P, Del Giglio M, Girolomoni G. Considerations for Systemic Treatment of Psoriasis in Obese Patients. Am J Clin Dermatol. 2016 Dec; 17(6):609-15. DOI: 10.1007/s40257-016-0211-7